371 related articles for article (PubMed ID: 30704985)
1. The CCR2
Bartneck M; Schrammen PL; Möckel D; Govaere O; Liepelt A; Krenkel O; Ergen C; McCain MV; Eulberg D; Luedde T; Trautwein C; Kiessling F; Reeves H; Lammers T; Tacke F
Cell Mol Gastroenterol Hepatol; 2019; 7(2):371-390. PubMed ID: 30704985
[TBL] [Abstract][Full Text] [Related]
2. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
3. PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target.
She S; Wu X; Zheng D; Pei X; Ma J; Sun Y; Zhou J; Nong L; Guo C; Lv P; Song Q; Zheng C; Liang W; Huang S; Li Q; Liu Z; Song Z; Li Y; Zhang Y; Kong W; You H; Xi J; Wang Y
J Hepatol; 2020 Mar; 72(3):506-518. PubMed ID: 31813573
[TBL] [Abstract][Full Text] [Related]
4. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
[TBL] [Abstract][Full Text] [Related]
5. TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2/CCR2 signaling.
Tu W; Gong J; Zhou Z; Tian D; Wang Z
Cell Death Dis; 2021 Sep; 12(10):882. PubMed ID: 34580284
[TBL] [Abstract][Full Text] [Related]
6. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.
Ehling J; Bartneck M; Wei X; Gremse F; Fech V; Möckel D; Baeck C; Hittatiya K; Eulberg D; Luedde T; Kiessling F; Trautwein C; Lammers T; Tacke F
Gut; 2014 Dec; 63(12):1960-1971. PubMed ID: 24561613
[TBL] [Abstract][Full Text] [Related]
7. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
[TBL] [Abstract][Full Text] [Related]
8. NOTCH Signaling via WNT Regulates the Proliferation of Alternative, CCR2-Independent Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Ye YC; Zhao JL; Lu YT; Gao CC; Yang Y; Liang SQ; Lu YY; Wang L; Yue SQ; Dou KF; Qin HY; Han H
Cancer Res; 2019 Aug; 79(16):4160-4172. PubMed ID: 31266773
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression.
Bao D; Zhao J; Zhou X; Yang Q; Chen Y; Zhu J; Yuan P; Yang J; Qin T; Wan S; Xing J
Oncogene; 2019 Jun; 38(25):5007-5020. PubMed ID: 30894684
[TBL] [Abstract][Full Text] [Related]
11. Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion.
Bartneck M; Koppe C; Fech V; Warzecha KT; Kohlhepp M; Huss S; Weiskirchen R; Trautwein C; Luedde T; Tacke F
Cell Mol Gastroenterol Hepatol; 2021; 11(2):327-347. PubMed ID: 32896623
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles.
Cortés M; Sanchez-Moral L; de Barrios O; Fernández-Aceñero MJ; Martínez-Campanario MC; Esteve-Codina A; Darling DS; Győrffy B; Lawrence T; Dean DC; Postigo A
EMBO J; 2017 Nov; 36(22):3336-3355. PubMed ID: 29038174
[TBL] [Abstract][Full Text] [Related]
13. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
[TBL] [Abstract][Full Text] [Related]
14. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
15. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
[TBL] [Abstract][Full Text] [Related]
16. Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway.
Fu C; Zhang Y; Xi WJ; Xu K; Meng F; Ma T; Li W; Wu L; Chen Z
J Ethnopharmacol; 2023 May; 308():116191. PubMed ID: 36731809
[TBL] [Abstract][Full Text] [Related]
17. CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.
Zhuang H; Cao G; Kou C; Liu T
Oncol Rep; 2018 Jan; 39(1):21-30. PubMed ID: 29115520
[TBL] [Abstract][Full Text] [Related]
18. Macrophages promote the transition from myocardial ischemia reperfusion injury to cardiac fibrosis in mice through GMCSF/CCL2/CCR2 and phenotype switching.
Shen SC; Xu J; Cheng C; Xiang XJ; Hong BY; Zhang M; Gong C; Ma LK
Acta Pharmacol Sin; 2024 May; 45(5):959-974. PubMed ID: 38225394
[TBL] [Abstract][Full Text] [Related]
19. Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1.
Lin N; Meng L; Lin J; Chen S; Zhang P; Chen Q; Lin Y
J Cell Biochem; 2020 Feb; 121(2):1441-1451. PubMed ID: 31609020
[TBL] [Abstract][Full Text] [Related]
20. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
